
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Kodo millet (Paspalum scrobiculatum) contains bioactive polyphenols including sinapic acid and syringic acid that inhibit α-glucosidase and α-amylase enzymes, supporting blood sugar regulation. These compounds also scavenge free radicals and reduce lipid peroxidation, providing antioxidant and anti-inflammatory effects.

Reported Benefits (Provisional)
Origin & History

Kodo Millet (Paspalum scrobiculatum) is an ancient grain native to India, Nepal, and parts of West Africa, thriving in diverse climates, including drought-prone regions. Valued for its hardiness and nutritional density, it has been a staple food in traditional diets for millennia. This resilient millet is recognized for its significant contributions to blood sugar regulation, digestive health, and cardiovascular function.
Research Narrative (Provisional)
Extensive research, including in vitro, animal, and some human studies, supports Kodo Millet's nutritional and glycemic benefits, highlighting its potential in blood sugar regulation and weight management. Studies also confirm its significant antioxidant and anti-diabetic properties, attributed to its rich profile of dietary fiber, protein, and polyphenols. Comparative analyses with other millets further underscore its functional food potential.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber - Protein - Lecithin - Iron - Magnesium - Phosphorus - Zinc - Polyphenols (e.g., phenolic acids, flavonoids)
Reported Mechanism (Provisional)
Kodo millet's polyphenols, particularly sinapic acid (3,5-dimethoxy-4-hydroxycinnamic acid) and syringic acid, inhibit carbohydrate-digesting enzymes α-glucosidase and α-amylase, reducing postprandial hyperglycemia. These compounds scavenge reactive oxygen species, inhibit ROS-producing enzymes like myeloperoxidase and lipoxygenase, and suppress glycation and cross-linking of collagen proteins.
Clinical Narrative (Provisional)
Current evidence is primarily limited to in vitro and animal studies, with no published human randomized controlled trials providing specific clinical outcomes. Animal studies demonstrate that polyphenol extracts improve antioxidant status and reduce lipid peroxides in diabetic rats fed kodo millet diets. Related millet research shows sinapic acid concentrations of 11.0-24.8 μg/g associated with anti-inflammatory effects, though specific kodo millet clinical quantification remains unavailable. Human clinical trials are needed to establish therapeutic dosages and confirm efficacy endpoints.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







